A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung

Name: A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung
License: Public Domain

Boehringer Ingelheim · clinicaltrials

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

squamous non-small cell lung cancer

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Record · ID 18581 · SHA-256 17c3746fc8cd5ac2
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.